Drawing for MED-CHEK

USPTO serial 77030764

MED-CHEK

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
MCBRIDE, THEODORE M
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MED-CHEK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
044Remote monitoring of data indicative of the health or condition of an individual or group of individualsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 25, 2007MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jul 25, 2007ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 20, 2007ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 28, 2007EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 9, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 5, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 6, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2007NPUBNOTICE OF PUBLICATION—
Jan 12, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 12, 2007ALIEASSIGNED TO LIE—
Dec 18, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 13, 2006DOCKASSIGNED TO EXAMINER—
Nov 1, 2006MPMKNOTICE OF PSEUDO MARK MAILED—
Oct 31, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance